시장보고서

상품코드

1819883

임상 미생물학 시장 분석 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

Clinical Microbiology Market Report by Product, Application, End User, and Region 2025-2033

발행일: 2025년 09월 | 리서치사:

IMARC | 페이지 정보: 영문 147 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 임상 미생물학 시장 규모는 2024년 47억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 77억 달러에 달하고, 2025-2033년 5.39%의 연평균 성장률(CAGR)을 보일 것으로 예측했습니다.

임상미생물학은 다양한 감염성 질환의 진단, 예방, 치료를 돕는 의학의 한 분야입니다. 세균, 바이러스, 곰팡이, 기생충의 존재를 확인하고 다양한 검사를 통해 미생물의 감수성을 판단하는 데 중점을 두고 있습니다. 일반적으로 사용되는 검사법에는 직접 도말-염색, 배양, 분자생물학적 분석, 혈청학적 검사, 항생제 감수성 검사 등이 있습니다. 현재 임상미생물학은 효과적인 항생제 투여와 치료 결과의 개선으로 전 세계적으로 각광받고 있습니다.

임상 미생물학 시장 동향 :

세계적으로 전염병의 확산이 증가하는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한 대기오염과 수질오염 증가로 인해 호흡기 질환 환자 수가 증가하고 있으며, 이것이 시장을 주도하고 있습니다. 이와는 별도로, 임상 미생물학에서 자동화의 통합은 시료의 추적성을 가능하게 하고, 배양 지연을 없애고, 실험실 작업의 효율성을 향상시켜 시장 성장에 유리한 전망을 만들어 내고 있습니다. 또한, 주요 기업들은 신속하고 정확한 결과를 제공하는 데 도움이 되는 머신러닝(ML)을 도입하는 등 질병 진단에 기술적 진보를 도입하는 데 주력하고 있습니다. 이는 여러 분자진단 기술의 도입과 함께 시장에 유리한 성장 기회를 제공합니다. 또한, 실시간 중합효소연쇄반응(PCR), 차세대염기서열분석(NGS), 병원균의 효과적인 동정 및 특성 분석을 위한 질량분석 등 첨단 임상 진단 기술의 채택이 증가하고 있는 것도 성장을 가속하는 요인 중 하나입니다. 이외에도 다양한 감염병을 유발하는 신종 미생물 증가, 전 세계적으로 급성장하고 있는 의료 분야 등이 시장 성장을 가속할 것으로 예측됩니다.

본 보고서에서 답변을 얻을 수 있는 주요 질문

2024년 세계 임상미생물학 시장 규모는?
세계 임상미생물학 시장의 2025-2033년 예상 성장률은?
코로나19가 세계 임상미생물학 시장에 미치는 영향은?
세계 임상 미생물학 시장을 이끄는 주요 요인은?
세계 임상미생물학 시장의 제품별 분류는?
세계 임상미생물학 시장의 용도별 분류는?
세계 임상미생물학 시장의 최종 사용자별 분류는?
세계 임상미생물학 시장의 주요 지역은?
세계 임상 미생물학 시장의 주요 기업은?

Clinical microbiology is a field of medical science that assists in diagnosing, preventing, and treating various infectious diseases. It focuses on identifying the presence of bacterial, viral, fungal, or parasitic agents and determining the susceptibility of microorganisms by conducting various tests. Some of the commonly used testing methods are direct smears and stains, cultures, molecular analysis, serological testing, and antibiotic susceptibility testing. Presently, clinical microbiology is gaining traction across the globe on account of its effective antibiotic administration and improved treatment outcomes.

Clinical Microbiology Market Trends:

The increasing prevalence of infectious diseases around the world represents one of the primary factors propelling the growth of the market. Additionally, the rising air and water pollution levels are increasing incidences of respiratory diseases among individuals, which, in turn, is driving the market. Apart from this, the integration of automation in clinical microbiology is creating a favorable outlook for market growth as it enables specimen traceability, eliminates delays in incubations and improves the efficiency of laboratory operations. Furthermore, the leading players are focusing on introducing technological advancements in disease diagnostics, such as the adoption of machine learning (ML), which aids in providing quick and accurate results. This, along with the introduction of several molecular diagnostic techniques, is offering lucrative growth opportunities to the market. Moreover, the rising adoption of advanced clinical diagnostic techniques, including real-time polymerase chain reaction (PCR), next-generation sequencing (NGS), and mass spectrometry for effective identification and characterization of pathogens, is acting as another growth-inducing factor. Other major factors, including the increasing number of new microorganisms causing various infectious diseases and the burgeoning healthcare sector across the globe, are anticipated to impel the growth of the market.

Key Market Segmentation:

Breakup by Product:

Laboratory Instruments
- Incubators
- Gram Stainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Petri Dish Fillers
Automated Culture Systems
- Microbiology Analyzers
- Molecular Diagnostic Instruments
- Microscopes
- Mass Spectrometers
Reagents

Breakup by Application:

Respiratory Diseases
Bloodstream Infections
Gastrointestinal Diseases
Sexually Transmitted Diseases
Urinary Tract Infections (UTIs)
Periodontal Diseases
Others

Breakup by End User:

Hospitals and Diagnostic Centers
Custom Lab Service Providers
Academic and Research Institutes

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc, Bruker Corporation, Danaher Corporation, Hologic Inc., Merck KGaA, QIAGEN N.V and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.What was the size of the global clinical microbiology market in 2024?
2.What is the expected growth rate of the global clinical microbiology market during 2025-2033?
3.What has been the impact of COVID-19 on the global clinical microbiology market?
4.What are the key factors driving the global clinical microbiology market?
5.What is the breakup of the global clinical microbiology market based on the product?
6.What is the breakup of the global clinical microbiology market based on the application?
7.What is the breakup of the global clinical microbiology market based on the end user?
8.What are the key regions in the global clinical microbiology market?
9.Who are the key players/companies in the global clinical microbiology market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Clinical Microbiology Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Laboratory Instruments
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Incubators
  - 6.1.2.2 Gram Stainers
  - 6.1.2.3 Bacterial Colony Counters
  - 6.1.2.4 Autoclave Sterilizers
  - 6.1.2.5 Petri Dish Fillers
- 6.1.3 Market Forecast
6.2 Automated Culture Systems
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Microbiology Analyzers
  - 6.2.2.2 Molecular Diagnostic Instruments
  - 6.2.2.3 Microscopes
  - 6.2.2.4 Mass Spectrometers
- 6.2.3 Market Forecast
6.3 Reagents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Application

7.1 Respiratory Diseases
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Bloodstream Infections
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Gastrointestinal Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Sexually Transmitted Diseases
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Urinary Tract Infections (UTIs)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Periodontal Diseases
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals and Diagnostic Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Custom Lab Service Providers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 3M Company
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Abbott Laboratories
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Agilent Technologies Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Becton Dickinson and Company
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 bioMerieux SA
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Bio-Rad Laboratories Inc
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Bruker Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Danaher Corporation
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Hologic Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Merck KGaA
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 QIAGEN N.V
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis

임상 미생물학 시장 분석 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

Clinical Microbiology Market Report by Product, Application, End User, and Region 2025-2033

임상 미생물학 시장 동향 :

본 보고서에서 답변을 얻을 수 있는 주요 질문

목차

제1장 서문

제2장 분석 범위 및 방법

제3장 주요 요약

제4장 서론

제5장 세계의 임상 미생물학 시장

제6장 시장 분석 : 제품별

제7장 시장 분석 : 용도별

제8장 시장 분석 : 최종사용자별

제9장 시장 분석 : 지역별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 Five Forces 분석

제13장 가격 분석

제14장 경쟁 구도